CN111321128A - Entada phaseolome cytochrome P450 gene and obtaining method and application thereof - Google Patents

Entada phaseolome cytochrome P450 gene and obtaining method and application thereof Download PDF

Info

Publication number
CN111321128A
CN111321128A CN202010139618.1A CN202010139618A CN111321128A CN 111321128 A CN111321128 A CN 111321128A CN 202010139618 A CN202010139618 A CN 202010139618A CN 111321128 A CN111321128 A CN 111321128A
Authority
CN
China
Prior art keywords
entada
gene
cytochrome
leu
epcyp93e1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010139618.1A
Other languages
Chinese (zh)
Inventor
廖卫芳
缪礼鸿
王科
王珍珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Polytechnic University
Original Assignee
Wuhan Polytechnic University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Polytechnic University filed Critical Wuhan Polytechnic University
Priority to CN202010139618.1A priority Critical patent/CN111321128A/en
Publication of CN111321128A publication Critical patent/CN111321128A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C12N9/0081Cholesterol monooxygenase (cytochrome P 450scc)(1.14.15.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/13Plant traits
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to an entada phaseolol P450 gene and an obtaining method and application thereof. The nucleotide sequence of the entada cytochrome P450 gene is shown as SEQ ID NO: 1 is shown. The invention determines the expression quantity change of the gene in different organ roots, stems and leaves of the entada phaseoloides and the response condition of the gene to methyl jasmonate, experiments show that the expression quantity of the gene is positively correlated with the content of entada phaseoloides in entada plants, show that the gene participates in the biosynthesis process of entada phaseoloides, and the cloning and research of the gene have reference value for analyzing the molecular mechanism of the biosynthesis route of the entada phaseoloides.

Description

Entada phaseolome cytochrome P450 gene and obtaining method and application thereof
Technical Field
The invention belongs to the technical field of biology, and particularly relates to an entada phaseolol P450 gene and an obtaining method and application thereof.
Background
Entada phaseoloides (Entada phaseoloides) is a plant of Entada of Leguminosae, also called caulis Entadae, Acer truncatum, Spatholobus lanceolata, etc. Entada phaseoloides as a traditional Chinese herbal medicine has the effects of resisting inflammation, treating gouty arthritis, resisting oxidation, resisting diabetes and the like. The main pharmacological active component is ketenin, namely triterpenoid saponin. The ketengwood saponin obtained naturally can not meet the clinical requirement because of the scarce ketengwood plant resource and the extremely low ketengwood saponin content. Establishing a synthetic biology technology of entada saponin is an important way for solving the contradiction between supply and demand.
In recent years, it has become a hot spot of scientific research to analyze the molecular mechanism of the triterpene saponin synthesis pathway and synthesize triterpene saponin by metabolic engineering means. The biosynthetic pathway of entagenin saponins is divided into three phases: (1) synthesizing terpenoid precursor compounds IPP and DMAPP; (2) constructing an entasaponin skeleton; (3) post-modification of the backbone. Most enzyme genes in the first two stages are identified, but cytochrome P450 genes participating in post-modification of the triterpene skeleton structure of entada phaseolol and the functions thereof are not completely analyzed, which is a main difficulty in comprehensively establishing an entada saponin synthetic biology technology at present.
Disclosure of Invention
The invention aims to provide an entada phaseoloides biosynthetic cytochrome P450 gene and an obtaining method and application thereof.
According to the invention, the full length of Entada phaseoloides EpCYP93E1 gene is obtained by gene screening, amplification by a PCR method, sequencing and splicing of the product; subsequently, bioinformatics analysis is carried out on the beta-phaseoloside-alpha-phaseoloside-beta-phaseoloside, the change of the expression quantity of the gene in roots, stems and leaves of different organs of the beta-phaseoloside-beta-phaseoloside is determined, and the response condition of the gene to methyl jasmonate (MeJA) is detected, so that the function of the gene in the biosynthesis of the beta-phaseoloside-beta-phaseolo.
Specifically, the first aspect of the present invention provides an entada cytochrome P450 gene EpCYP93E1, the nucleotide sequence of which is as set forth in SEQ ID NO: 1 is shown. The total length of CDS is 1542bp, and 513 amino acids are coded.
A second aspect of the present invention provides an entada phaseolol biosynthesis-associated protein encoded by the entada cytochrome P450 gene EpCYP93E1, and having an amino acid sequence shown in SEQ ID NO: 2, respectively. The amino acid sequence of the entada saponin biosynthesis-related protein comprises a typical conserved domain of cytochrome P450 oxidase.
The third aspect of the present invention provides a method for obtaining the entada phaseolol P450 gene EpCYP93E1, comprising the steps of:
1) extracting total RNA of the sample of the young Entada phaseoloides leaves;
2) carrying out PCR amplification by taking cDNA obtained by reverse transcription of the RNA extracted in the step 1) as a template to obtain a cDNA full-length fragment of Entada phaseoloides EpCYP93E1 gene, wherein the nucleotide sequence of a specific primer used in the PCR amplification is as follows:
93E1-F:5’-ATGCTAGATATCCAAGGCTACTTCG-3’(SEQ ID NO:3)
93E1-R:5’-TCAGGCAGCAGAAAATGGAAC-3’(SEQ ID NO:4)
3) recovering the PCR product obtained in step 2).
The fourth aspect of the present invention provides an application of the entada cytochrome P450 gene EpCYP93E1 or the entada saponin biosynthesis-associated protein in entada saponin biosynthesis.
The technical scheme of the invention achieves the following beneficial effects:
1) the Entada phaseoloides cytochrome P450 gene EpCYP93E1 is an Entada phaseoloides saponin biosynthesis related cytochrome P450 oxidase gene in Entada phaseoloides, which is an active ingredient, and the invention determines the expression quantity change of the gene in roots, stems and leaves of different organs of the Entada phaseoloides and the response condition of the gene to methyl jasmonate.
2) The invention discloses the function of the gene in the biosynthesis of entada phaseoloides, and the acquisition of the gene lays a foundation for the large-scale and low-cost production of entada phaseoloides by using a synthetic biology technology.
Additional features and advantages of the invention will be set forth in the detailed description which follows.
Drawings
The above and other objects, features and advantages of the present invention will become more apparent by describing in more detail exemplary embodiments thereof with reference to the attached drawings.
FIG. 1 shows the result of agarose gel electrophoresis detection of RNA integrity of young leaves of wild Entada phaseoloides.
Fig. 2 shows the result of agarose gel electrophoresis detection of the CDS full-length sequence of the entada EpCYP93E1 gene.
Figure 3 shows the conserved domain prediction of EpCYP93E 1.
Figure 4 shows the transmembrane domain prediction of EpCYP93E 1.
Fig. 5 shows the expression level difference of EpCYP93E1 in the roots, stems, and leaves of different organs of entada phaseoloides.
Fig. 6 shows the difference in the expression level of EpCYP93E1 induced by methyl jasmonate.
Detailed Description
Preferred embodiments of the present invention will be described in more detail below. While the following describes preferred embodiments of the present invention, it should be understood that the present invention may be embodied in various forms and should not be limited by the embodiments set forth herein.
Example 1
In this example, a cytochrome P450 oxidase gene was cloned by using a PCR method using a wild-type entada phaseoloides cDNA as a template, and the specific steps were as follows:
1) taking young Entada phaseoloides leaves as a material, and extracting the total RNA of the Entada phaseoloides. Total RNA extraction was performed according to the procedures described in the Promega RNA extraction kit, and then detected by electrophoresis on 1.5% agarose gel containing staining solution EB (shown in FIG. 1), which indicated successful extraction of total RNA. cDNA was synthesized according to the procedures described in the Thermo reventaid First Strand cDNAsSynthesis Kit, and was stored in a-20 ℃ freezer after being dispensed.
2) Primer design and PCR amplification:
in the aspect of primer design, partial cytochrome P450 enzyme gene sequences are screened by sequencing of transcription groups of roots, stems and leaves of different organs of the Entada phaseoloides at the early stage of a project group, and the P450 oxidase family genes are found to play an important role in the biosynthesis Pathway of Entada phaseoloides by combining the analysis of expression quantity difference, GO annotation, Pathway metabolism and the like. Therefore, based on an entada phaseolol cytochrome P450 oxidase gene sequence, the Primer 6.0 software is used to design a specific Primer, and the nucleotide sequence is as follows:
93E1-F:5’-ATGCTAGATATCCAAGGCTACTTCG-3’(SEQ ID NO:3)
93E1-R:5’-TCAGGCAGCAGAAAATGGAAC-3’(SEQ ID NO:4)
the specific method of PCR is as follows:
A) PCR reaction (25. mu.L):
10 × PCR Buffer 2.5. mu.L, dNTPs (10mmol/L, 2.5mmol each) 2. mu.L, forward and backward primers (10mmol/L) 1. mu.L each, DNA template (50ng/L) 1. mu.L, Takara-LA Hi-Fi enzyme (5U/L) 0.5. mu.L, using ddH2And O is supplemented to 25 mu L.
B) And (3) PCR reaction conditions:
pre-denaturation at 94 ℃ for 4 min; denaturation at 95 deg.C for 1min, annealing at 55 deg.C for 30s, and extension at 72 deg.C for 30s, and circulating for 35 times; extending for 10min at 72 ℃;
C) recovery, sequencing and sequence analysis of PCR products:
detecting a PCR product by using 1% agarose gel containing staining solution EB, generating a specific target band at 1542bp (figure 2), recovering a target fragment by using a Tiangen centrifugal column type agarose gel DNA recovery kit, connecting the target fragment with a PMD19-T carrier, connecting the target fragment at 16 ℃ for 2-3 hours, transforming the target fragment into escherichia coli DH5 α competent cells, coating the escherichia coli DH5 α competent cells on an LB agar plate culture medium containing AMP, inverting the cells overnight for culture at 37 ℃ to form a single colony, randomly selecting the single colony, inoculating the single colony in a liquid LB culture medium containing AMP, shaking the culture overnight, amplifying the single colony by using a carrier general M13 primer provided by Shanghai's engineering, identifying positive clones, sequencing and splicing to obtain a CDS full-length sequence of Entada EpCYP93E1 gene.
Example 2
This example carried out bioinformatics analysis of the Entada phaseoloides gene cloned in example 1, and confirmed by cluster analysis and amino acid sequence alignment that the gene belongs to the cytochrome P450 oxidase gene family and has high homology with cytochrome P450 oxidase gene in pea. The method comprises the following specific steps:
a cDNA sequence is obtained by cloning through a PCR technology, the length is 1542bp, 513 amino acids are coded and named as EpCYP93E1, and the nucleotide sequence of the cDNA sequence is shown as SEQ ID NO: 1 is shown. The predicted protein has a molecular weight of about 57.97kDa and an isoelectric point of 8.97, and has the amino acid sequence shown in SEQ ID NO: 2, or a pharmaceutically acceptable salt thereof. The conserved region of the amino acid sequence of EpCYP93E1 was predicted by Blastp (FIG. 3), and the sequence was shown to contain the typical conserved domain of cytochrome P450. The transmembrane domain was predicted by TMHMM2.0Server (http:// www.cbs.dtu.dk/services/TMHMM /), and the result showed that the protein contained 1 transmembrane region (7-25 aa) and had a predicted number of transmembrane helices of 24.07617, so that the protein was presumed to belong to a transmembrane protein (FIG. 4).
Example 3
In this example, real-time fluorescent quantitative PCR analysis indicates that the expression level of EpCYP93E1 is related to the content of ketenaside in ketena plants, and the function thereof is further confirmed. The method comprises the following specific steps:
1) respectively cutting root, stem and leaf of different organs of Entada phaseoloides, quickly freezing with liquid nitrogen, and storing in a refrigerator at-80 deg.C. Three replicates were used.
2) Preparing 0.1mmol/L methyl jasmonate solution, uniformly spraying onto plant leaves, picking the plant leaves after 6h, quickly freezing by liquid nitrogen, and storing in a refrigerator at-80 deg.C for later use. The control group was prepared from leaves of plants sprayed with ethanol. Three replicates were used.
3) Before reverse transcription, the concentration of the extracted total RNA is adjusted, the RNA to be subjected to reverse transcription of each sample is diluted to the same concentration, the reverse transcription is carried out to obtain cDNA, β -actin gene is taken as an internal reference gene to carry out real-time fluorescence quantitative PCR, each experiment is repeated for three times, and the expression difference of EpCYP93E1 in roots, stems and leaves of different organs of a ketchup and the response condition of induction of methyl jasmonate are detected, wherein the nucleotide sequences of the newly designed quantitative primers of the ketchup β -actin and EpCYP93E1 are as follows:
β-actin-F:5’-TTGGACTGTGCCTCATCACC-3’(SEQ ID NO:5)
β-actin-R:5’-CTTCCATCACCCTCGGCATT-3’(SEQ ID NO:6)
dl-93E1-F:5’-CTTTGTCAGCATTCGCGAGG-3’(SEQ ID NO:7)
dl-93E1-R:5’-ATCAGTGGTCCCGCTACTCT-3’(SEQ ID NO:8)
fluorescent quantitative PCR reaction system (20 μ L)2 × SYBR Green qPCR Master Mix 10 μ L, upstream and downstream primers (10mmol/L) each 1 μ L, template 1 μ L, and ddH2And O is supplemented to 20 mu L.
Fluorescent quantitative PCR reaction conditions: pre-denaturation at 95 ℃ for 4min, denaturation at 95 ℃ for 1min, annealing at 55 ℃ for 30s, extension at 72 ℃ for 30s, and circulation for 40 times; three replicates per sample.
The results shown in fig. 5 indicate that EpCYP93E1 is expressed in high amounts in the stem. The preliminary research results of the subject groups show that the content of entada saponin in stems is high, which indicates that the expression quantity of EpCYP93E1 is related to the content of entada saponin. Methyl jasmonate can enter the plant body from the stomata of the plant due to the volatility and molecular characteristics of the methyl jasmonate, so that the synthesis of secondary metabolites of the plant is promoted. The results shown in fig. 6 indicate that the expression level of EpCYP93E1 gene was significantly increased after methyl jasmonate induction, and thus, it was confirmed that the gene was involved in the biosynthesis process of entada phaseoloides.
The EpCYP93E1 gene cloned by the invention not only provides a valuable candidate functional gene for revealing the molecular mechanism of the biosynthesis pathway of entagenin saponin, but also provides an important theoretical basis for producing the entagenin saponin in a large scale and at low cost by utilizing the synthetic biology technology.
Having described embodiments of the present invention, the foregoing description is intended to be exemplary, not exhaustive, and not limited to the embodiments disclosed. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments.
Sequence listing
<110> Wuhan university of light industry
<120> Entada phaseolol P450 gene and obtaining method and application thereof
<130>BJI2000176WHPU
<160>8
<170>SIPOSequenceListing 1.0
<210>1
<211>1542
<212>DNA
<213>Entada phaseoloides
<400>1
atgctagata tccaaggcta cttcgtgtta ttcctcttat ggttcatatc caccattttg 60
attagatcca ttttcaaaaa atctgtgtgt tatagactac ccccaggtcc cccaatttca 120
ttgccactca ttggacacgc tccttatctc cgatcactcc ttcaccaagc actctacaag 180
ctctccaccc gatatgggcc cttgatgcat gtcttgattg gttccaagca tgtcattgtt 240
gcatcatctg ctgaaatggc aaagcaaatc ctcaagactt atgaggagtc attttgcaac 300
cgccccatca tgattgcaag tgagaacttg acttatggtg ctgctgacta cttcttcatc 360
ccttatggaa cctactggag gttcctcaag aagctctgca tgactgagct tcttagtggg 420
aaaactctgg agcactttgt cagcattcgc gaggatgaaa tccaggcctt cctgaagacg 480
attctgcaga tagctaacac cggtaaagcg gtggagatga ggcaagaact aatcaggcat 540
accaacaaca tcatttcgag gatgacaatg ggaaagaaga gtagcgggac cactgatgag 600
gttggtcagt tgaggaaggt gattagggag attggagagc tccttggagc gtttaatctt 660
ggtgatatca ttgggttcat gaggcctctt gatctgcaag gatttgggaa gaagaacaag 720
gacactcacc acaagatgga tatgatgatg gagaaggtgc taaaggagca tgaagaggcc 780
agggcaaagg agggtgctga tagtgatagg aagaaggatc tttttgacat tttgttgaac 840
ttgattgaag cagatggagc agacagcaaa ctcactagag aaagtgccaa agcctttgct 900
ctggacatgt ttattgccgg gacaaacggg cctgcaagtg tgttggagtg gtcactagca 960
gagctggtta gaaacccaca cgttttgaag aaggctagag aagagattga aactgttgtt 1020
ggcaaggaca ggctggttaa agaatcagat atacccaacc taccttatct ccaagcaata 1080
gtgaaggaaa ctttgaggat gcacccacca accccaatat ttgcaagaga agccatcaga 1140
ggctgccagg ttgatggcta tgatatccct gcacattcaa agattttcat caatgcatgg 1200
gccattggta gggacccaaa atactgggac aacccagatg tgtatagccc tgagaggttc 1260
ttacacagag atgaaccagg gaagagcaag atagatgtga gggggcaata ttaccaactc 1320
ttgccatttg ggagtgggag aagaagctgc cctggtagtt cccttgcatt gctggttatc 1380
caagcaacac tggcaagctt ggtacagtgc tttgattggg ttgttaatga tggtaagaat 1440
aatgacattg acatgtcaga ggtaggaagg gtgactgtgt tcttggccaa gccactgaag 1500
tgcaagcctg tttcccgttt tgttccattt tctgctgcct ga 1542
<210>2
<211>513
<212>PRT
<213>Entada phaseoloides
<400>2
Met Leu Asp Ile Gln Gly Tyr Phe Val Leu Phe Leu Leu Trp Phe Ile
1 5 10 15
Ser Thr Ile Leu Ile Arg Ser Ile Phe Lys Lys Ser Val Cys Tyr Arg
20 25 30
Leu Pro Pro Gly Pro Pro Ile Ser Leu Pro Leu Ile Gly His Ala Pro
35 40 45
Tyr Leu Arg Ser Leu Leu His Gln Ala Leu Tyr Lys Leu Ser Thr Arg
50 55 60
Tyr Gly Pro Leu Met His Val Leu Ile Gly Ser Lys His Val Ile Val
65 70 75 80
Ala Ser Ser Ala Glu Met Ala Lys Gln Ile Leu Lys Thr Tyr Glu Glu
85 90 95
Ser Phe Cys Asn Arg Pro Ile Met Ile Ala Ser Glu Asn Leu Thr Tyr
100 105 110
Gly Ala Ala Asp Tyr Phe Phe Ile Pro Tyr Gly Thr Tyr Trp Arg Phe
115 120 125
Leu Lys Lys Leu Cys Met Thr Glu Leu Leu Ser Gly Lys Thr Leu Glu
130 135 140
His Phe Val Ser Ile Arg Glu Asp Glu Ile Gln Ala Phe Leu Lys Thr
145 150 155 160
Ile Leu Gln Ile Ala Asn Thr Gly Lys Ala Val Glu Met Arg Gln Glu
165 170 175
Leu Ile Arg His Thr Asn Asn Ile Ile Ser Arg Met Thr Met Gly Lys
180 185 190
Lys Ser Ser Gly Thr Thr Asp Glu Val Gly Gln Leu Arg Lys Val Ile
195 200 205
Arg Glu Ile Gly Glu Leu Leu Gly Ala Phe Asn Leu Gly Asp Ile Ile
210 215 220
Gly Phe Met Arg Pro Leu Asp Leu Gln Gly Phe Gly Lys Lys Asn Lys
225 230 235 240
Asp Thr His His Lys Met Asp Met Met Met Glu Lys Val Leu Lys Glu
245 250 255
His Glu Glu Ala Arg Ala Lys Glu Gly Ala Asp Ser Asp Arg Lys Lys
260 265 270
Asp Leu Phe Asp Ile Leu Leu Asn Leu Ile Glu Ala Asp Gly Ala Asp
275 280 285
Ser Lys Leu Thr Arg Glu Ser Ala Lys Ala Phe Ala Leu Asp Met Phe
290 295 300
Ile Ala Gly Thr Asn Gly Pro Ala Ser Val Leu Glu Trp Ser Leu Ala
305 310 315 320
Glu Leu Val Arg Asn Pro His Val Leu Lys Lys Ala Arg Glu Glu Ile
325 330 335
Glu Thr Val Val Gly Lys Asp Arg Leu Val Lys Glu Ser Asp Ile Pro
340 345 350
Asn Leu Pro Tyr Leu Gln Ala Ile Val Lys Glu Thr Leu Arg Met His
355 360 365
Pro Pro Thr Pro Ile Phe Ala Arg Glu Ala Ile Arg Gly Cys Gln Val
370 375 380
Asp Gly Tyr Asp Ile Pro Ala His Ser Lys Ile Phe Ile Asn Ala Trp
385 390 395 400
Ala Ile Gly Arg Asp Pro Lys Tyr Trp Asp Asn Pro Asp Val Tyr Ser
405 410 415
Pro Glu Arg Phe Leu His Arg Asp Glu Pro Gly Lys Ser Lys Ile Asp
420 425 430
Val Arg Gly Gln Tyr Tyr Gln Leu Leu Pro Phe Gly Ser Gly Arg Arg
435 440 445
Ser Cys Pro Gly Ser Ser Leu Ala Leu Leu Val Ile Gln Ala Thr Leu
450 455 460
Ala Ser Leu Val Gln Cys Phe Asp Trp Val Val Asn Asp Gly Lys Asn
465 470 475 480
Asn Asp Ile Asp Met Ser Glu Val Gly Arg Val Thr Val Phe Leu Ala
485 490 495
Lys Pro Leu Lys Cys Lys Pro Val Ser Arg Phe Val Pro Phe Ser Ala
500 505 510
Ala
<210>3
<211>25
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>3
atgctagata tccaaggcta cttcg 25
<210>4
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>4
tcaggcagca gaaaatggaa c 21
<210>5
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>5
ttggactgtg cctcatcacc 20
<210>6
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>6
cttccatcac cctcggcatt 20
<210>7
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>7
ctttgtcagc attcgcgagg 20
<210>8
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>8
atcagtggtc ccgctactct 20

Claims (4)

1. An entada cytochrome P450 gene EpCYP93E1, characterized in that the nucleotide sequence is as shown in SEQ ID NO: 1 is shown.
2. An entada phaseoloside biosynthesis-related protein encoded by the entada cytochrome P450 gene EpCYP93E1 of claim 1, having an amino acid sequence shown in SEQ ID NO: 2, respectively.
3. The method for obtaining an entada cytochrome P450 gene EpCYP93E1 according to claim 1, comprising the steps of:
1) extracting total RNA of the sample of the young Entada phaseoloides leaves;
2) carrying out PCR amplification by taking cDNA obtained by reverse transcription of the RNA extracted in the step 1) as a template to obtain a cDNA full-length fragment of Entada phaseoloides EpCYP93E1 gene, wherein the nucleotide sequence of a specific primer used in the PCR amplification is as follows:
93E1-F:5’-ATGCTAGATATCCAAGGCTACTTCG-3’(SEQ ID NO:3)
93E1-R:5’-TCAGGCAGCAGAAAATGGAAC-3’(SEQ ID NO:4)
3) recovering the PCR product obtained in step 2).
4. Use of the entada cytochrome P450 gene EpCYP93E1 of claim 1 or the entada saponin biosynthesis-associated protein of claim 2 in the biosynthesis of entada saponin.
CN202010139618.1A 2020-03-03 2020-03-03 Entada phaseolome cytochrome P450 gene and obtaining method and application thereof Pending CN111321128A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010139618.1A CN111321128A (en) 2020-03-03 2020-03-03 Entada phaseolome cytochrome P450 gene and obtaining method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010139618.1A CN111321128A (en) 2020-03-03 2020-03-03 Entada phaseolome cytochrome P450 gene and obtaining method and application thereof

Publications (1)

Publication Number Publication Date
CN111321128A true CN111321128A (en) 2020-06-23

Family

ID=71165497

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010139618.1A Pending CN111321128A (en) 2020-03-03 2020-03-03 Entada phaseolome cytochrome P450 gene and obtaining method and application thereof

Country Status (1)

Country Link
CN (1) CN111321128A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6069241A (en) * 1997-03-03 2000-05-30 Suntory Limited Cytochrome P450 gene
CN102676549A (en) * 2012-01-09 2012-09-19 中国中医科学院中药研究所 CYP450 (Cytochrome P450) gene participating in tanshinone biosynthesis and coded product as well as application thereof
CN107287169A (en) * 2017-08-03 2017-10-24 扬州大学 A kind of eggplant cytochrome P450 gene StCYP84A and its preparation method and application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6069241A (en) * 1997-03-03 2000-05-30 Suntory Limited Cytochrome P450 gene
CN102676549A (en) * 2012-01-09 2012-09-19 中国中医科学院中药研究所 CYP450 (Cytochrome P450) gene participating in tanshinone biosynthesis and coded product as well as application thereof
CN107287169A (en) * 2017-08-03 2017-10-24 扬州大学 A kind of eggplant cytochrome P450 gene StCYP84A and its preparation method and application

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GENBANK: "AB437320.1", 《GENBANK》 *
GENBANK: "BAG68930.1", 《GENBANK》 *
HIKARU SEKI,等: "Licorice beta-amyrin 11-oxidase, a cytochrome P450 with a key role in the biosynthesis of the triterpene sweetener glycyrrhizin", 《PROC NATL ACAD SCI U S A》 *
HIKARU SEKI,等: "P450s and UGTs: Key Players in the Structural Diversity of Triterpenoid Saponins", 《PLANT CELL PHYSIOL》 *
HONGMEI LUO 等: "Analysis of the transcriptome of Panax notoginseng root uncovers putative triterpene saponin-biosynthetic genes and genetic markers", 《BMC GENOMICS》 *
WEIFANG LIAO 等: "Comparative transcriptome analysis of root, stem, and leaf tissues of Entada phaseoloides reveals potential genes involved in triterpenoid saponin biosynthesis", 《BMC GENOMICS》 *

Similar Documents

Publication Publication Date Title
CN106749572B (en) Participate in the transcription factor and its application of regulation muskmelon bitter principle synthesis
CN105647943B (en) Saussurea involucrate cell squalene synthase gene SiSQS and coded product and application thereof
CN112852650B (en) Saccharomyces cerevisiae engineering bacterium for high yield of santalene and santalol and construction method and application thereof
CN114891803B (en) Ginseng PgWRKY40 gene induced by methyl jasmonate and application thereof
CN114774439B (en) Tea tree CsFAAH6 gene and application thereof
CN111154790B (en) Oxidosqualene cyclase gene GpOSC1 and encoding product and application thereof
CN110894221B (en) Strawberry maturation associated transcription factor gene FaNAC2 and application thereof
CN109486831B (en) Carmine radish anthocyanin biosynthesis regulatory gene RsAN1 and application thereof
CN107629120B (en) Application of birch bHLH9 protein in regulation and control of triterpenoid synthesis
CN106518994B (en) Participate in the transcription factor and its application of regulation watermelon bitter principle synthesis
CN112251451A (en) Gene for encoding GA20 ox-oxidase and application thereof
CN106047895B (en) Artemisia apiacea bZIP transcription factor coding sequence, cloning method and application
CN112680483A (en) Application of sanshool dehydrogenase LcADH31 in preparation of citral or product with citral as active substance
CN111321128A (en) Entada phaseolome cytochrome P450 gene and obtaining method and application thereof
Jeong et al. Molecular cloning and characterization of CONSTANS-like cDNA clones of the Fuji apple
CN114438102B (en) Strawberry ethylene response FaERF13 gene and application thereof in changing strawberry fruit maturity
CN113832167B (en) Gene and application thereof in increasing yield of phenethyl alcohol and tryptophane
JP6856639B2 (en) Dorimenol synthase III
CN104894150B (en) Saussurea involucrate cell phenylalanine ammonia lyase gene SiPAL and encoding product and application thereof
CN113151231A (en) Rhododendron phenylalanine ammonia lyase PAL protein, coding gene and gene cloning method thereof
CN113999828A (en) Application of MTA and MTB genes of strawberry methyltransferase in controlling strawberry maturity
CN112410362A (en) Rhododendron micranthum TPS gene, primer for cloning Rhododendron micranthum TPS gene, cloning method and application thereof
CN111647589A (en) Euphorbia dienol synthase and coding gene and application thereof
CN106967731B (en) tamarix chinensis salt stress response key gene TcARF6 and application thereof
CN117106819B (en) Phaeodactylum tricornutum CHLC gene and application of encoded protein in chlorophyll c synthesis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200623